Clinical Studies of Mild Cognitive Impairment
The medical community – from researchers to clinicians – have made a lot of progress in the last two decades understanding and defining the various stages of memory loss and cognitive decline. Mild Cognitive Impairment was first defined as a separate diagnosis in 1999. It is now becoming more widely known among primary care physicians and the general public, and it is a major focus of current research.
Mild Cognitive Impairment can be the symptomatic pre-dementia phase of Alzheimer’s disease. With researchers now focusing their efforts on learning how to halt Alzheimer’s disease before significant memory loss has occurred, individuals with Mild Cognitive Impairment have many opportunities to get involved in promising research studies.
You can also check out the Alzheimer’s Association’s national list of trials to join a clinical study of MCI. Find a trial on TrialMatch here.